Cervical cancer is a malignancy of the cervix. World-wide, it is the second most common cancer of women. It may be present with vaginal bleeding but symptoms may be absent until the cancer is in advanced stages, which has made cervical cancer the focus of intense screening efforts. Most scientific studies point to human papillomavirus (HPV) infection responsible for 90 percent of the cases of cervical cancer. There are 7 most common types of HPV - 16, 18, 31, 33, 42, 52 and 58. Types 16 and 18 being the most common cause of the cancer. Treatment is with surgery (including local exicision) in early stages and chemotherapy and radiotherapy in advanced stages of the disease. This book presents cutting edge research in this field. This involves, programs for cancer screening, alternative approaches to cervical cancer prevention, HPV/Co-Infections and Host Genetic Profiles, Small Cell Carcinoma of the Uterine Cervix, Indicators of HPV-induced carcinogenesis, functional genomics as a tool for understanding cervical cancer, histone deacetylase inhibitors, Chinese women and cervical cancer and cervical cancer in Northeastern Thailand.